Gilead Sciences said on Thursday its HIV drug sales rose 4% to $5.3 billion in the third quarter including $39 million for ...

Biogen beat Wall Street estimates for third-quarter profit, helped by better-than-expected sales of some of its multiple ...

Nvidia (NASDAQ:NVDA) shares pared earlier gains on Thursday, losing about 2% value after U.S. President Donald Trump said he ...

We're not losing them to the competition. We're losing them to grocery and food at home,” Scott Boatwright said.

China's promise to delay its newest restrictions on the export of the rare earths that are crucial to many high-tech products ...

Delta Air Lines called for an end to the government shutdown as workers start to miss paychecks and many work "mandatory ...

U.S. President Donald Trump's Department of Government Efficiency initiative, or DOGE, has wrapped up work at the Securities ...

Apple's iPhone sales growth decelerated during its summertime quarter, but the company still delivered financial results that ...

Tech shares on Wall Street took a beating on Thursday after some megacap earnings reports, while the dollar and U. bond ...

Global shares dropped on Thursday and were set for their biggest daily decline in three weeks, weighed down by megacaps ...

LONDON (Reuters) -Novo Nordisk's late bid to hijack Pfizer's takeover of U. obesity biotech Metsera marks an aggressive shift ...

Centene on Wednesday raised its 2025 adjusted profit forecast and said it looks to grow its earnings next year, sending ...